Aimed Alliance and HR.com have launched a new webpage highlighting our 2024 survey findings; infographic, and webinar for employers and…
The Oregon Prescription Drug Affordability Board is currently reviewing the affordability of 27 selected medications and has requested feedback from…
On April 22, 2025, Aimed Alliance released a new resource titled “Tariffs 101: How Tariffs Could Impact Patients.” Since the start…
On January 14, 2024, the Federal Trade Commission (FTC) released its second report investigating the pharmacy benefit manager (PBM) industry.…
Currently, Medicare coverage for anti-obesity medications is limited to indications for diabetes and cardiovascular disease. Policymakers, however, have proposed expanding…
On October 10, 2024, the National AI Advisory Committee released its draft transition plan for the incoming administration. The…
On August 28, 2024, The AIDS Institute released an analysis revealing that despite laws banning copay accumulator policies, health insurance…
On September 3, 2024, Aimed Alliance sent letters to Illinois Senate Majority Leader Kimberly Lightford and House Majority Robyn Gabel,…
On March 20, 2023, Aimed Alliance released a new fact sheet titled “Alternative Funding Programs: The Cost Sharing Program That…
In 2022, Aimed Alliance recognized that health disparities exist in the inflammatory bowel disease (“IBD”) patient population. With rates of…